SUMMARY Histocompatibility antigens were determined in 60 patients with psoriatic arthritis. The patients were divided into clinical subgroups according to axial or peripheral joint involvement, disease severity based on number of peripheral joints involved, and the presence or absence of bone erosions. The total group showed a significant increase in frequency of HLA-A1, B17, B27, and DR7 when compared with a control population. The subgroup with spondylitis had a significant increase in frequency of HLA-B27 when compared with patients with peripheral arthritis (p<0-001). The subgroup with peripheral arthritis alone had a higher frequency of HLA-DR7 than the control group (p<0.001). There were also significant associations between HLA-DR7 and chronic severe disease (p<0-001) and between HLA-DR4 and the presence of erosions (p<O0O5).
The genetic predisposition to psoriasis and psoriatic arthritis has been the subject of many studies. There have been a number of reported associations with major histocompatibility complex class I antigens, the most significant being the association of psoriatic spondylitis with HLA-B27.' In patients with psoriasis there is an increased frequency of HLA-A1, B13, B17, and Cw6,26 and in those with arthritis an increase in HLA-A26, B27, B38, B39, and Cw6 '-' HLA-B38 being associated with a peripheral arthritis.8
The association with class II antigens is more controversial. HLA-DR4 has been associated with seropositive rheumatoid arthritis,'5 ankylosing spondylitis with peripheral joint involvement,'6 and occasionally psoriatic arthritisi1") In psoriatic arthritis HLA-DR4 may be associated with more severe arthritisl' and HLA-DR3 with the presence of erosions."' HLA-DR7 is increased in psoriatic arthritis8 9 11 
Results
In the total patient group there was a significant increase in HLA-A1 (p<0.02), B17 (p<002), B27 (p<0001), and DR7 (p<001) ( Table 1) . HLA-B38 and HLA-B39 were not increased in either the total group or in those with peripheral arthritis. There was a highly significant increase of HLA-DR7 in the group with peripheral arthritis (p<0 001).
The association of HLA-B27 with spondylitis or axial disease was highly significant compared with both the control population and with those with peripheral arthritis alone. The four patients who had spondylitis only were all male and all HLA-B27 positive. HLA-B27 was not significantly increased in peripheral disease (Table 1) .
There were six patients with peripheral arthritis and axial involvement who did not fulfil the criteria of spondylitis, three with cervical spine involvement and three with unilateral sacroiliitis. Only one of this group with unilateral sacroiliitis was HLA-B27 positive.
There were eight patients with significant cervical spine involvement clinically or radiologically. There may have been others with subclinical involvement who were not x rayed. Six of the eight were HLA-DRI positive. Three of the eight, all female, did not meet the criteria for spondylitis, yet had severe cervical spine involvement with ankylosis and peripheral joint disease, and their sacroiliac joints were radiologically normal. These three were HLA-B27 negative. The other five had clinical and radiological spondylitis, four were HLA-B27 positive, and one of these had normal sacroiliac joints.
The group with severe peripheral arthritis had an increased frequency of HLA-A1, B17, and DR7 when compared with the control population, and 'p<O)05 compared with control group and othcr subgroup.
increased HLA-B17 and DR7 and reduced HLA-DR2 when compared with patients with moderate and mild disease ( Table 2 ). The group with severe disease also had longer duration of the disease, 20 9 (SD 12-9) years, compared with 105 (9.5) years for moderate disease and 7-6 (8.6) years for mild disease. HLA-DR4 was associated only with moderately severe and not severe disease. There was a strong female predominance in the group with severe disease, 12 of the 14 being female. The patients with bone erosions had a significantly higher frequency of HLA-DR4 than those without ( Table 3 ). The duration of the disease was similar between those positive and those negative for HLA-DR4, 12-4 (SD 11 3) and 11-1 (11-6) years respectively. Bone erosions were more common in women.
Discussion
The results of this study confirm the known associations between psoriatic arthritis and HLA antigens Al, B17, B27, and DR7. Clinical subgroups need to be considered in order to There have been conflicting reports regarding the incidence of HLA-B27 in association with peripheral arthritis. Some report an increased incidence' 2 12 and others no association.'"" The reason for this discrepancy is unclear, particularly as the three positive studies cited had radiological evidence of normal sacroiliac joints in patients with peripheral arthritis who were HLA-B27 positive. Longitudinal data would be useful in assessing whether these patients develop sacroiliitis at a later date.
The pattern of arthritis seen may also have a major bearing. When we classified our patients according to the five subgroups described by Moll and Wright'7 (Table 4) there was an unusually high incidence of polyarticular as opposed to oligoarticular peripheral joint involvement. This may reflect the pattern of referral to a specialist rheumatology unit, where patients with mild or limited arthritis are not necessarily seen. though it has been suggested as a marker for disease severity in this group. 1 The results in our patients, all of whom were seronegative for IgM and IgG rheumatoid factor, would support the concept of HLA-DR4 being a marker for the development of erosions. If one considers the presence of erosions to be a better marker of disease severity than the total number of peripheral joints involved which may reflect disease chronicity, then HLA-DR4 is also a marker for disease severity.
In conclusion, our male patients tended to have spondylitic disease and the female patients peripheral arthritis, which was more likely to be erosive. Among the many genes that confer susceptibility to psoriatic arthritis we confirmed some of the known histocompatibility associations. In addition, HLA-DR7 may be associated with peripheral disease which is more likely to be chronic and severe, and HLA-DR4 with the development of 
